Clinical Trial Update: Midodrine Versus Albumin for Prevention of Paracentesis Induced Circulatory Disturbance [Phase 3]

View source ↗

Summary

Phase 3 trial comparing midodrine to albumin for prevention of paracentesis-induced circulatory disturbance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paracentesis-induced Circulatory Dysfunction

Drugs mentioned

• Albumin
• Midodrine (Midodrine)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Paracentesis-Induced Circulatory Dysfunction | Phase 3 | Status: COMPLETED